ObsEva SA

Symbol: OBSV




Market price today

  • -0.3137

    P/E Ratio

  • 0.0057

    PEG Ratio

  • 11.00M

    MRK Cap

  • 0.00%

    DIV Yield

ObsEva SA (OBSV) Stock Price & Analysis

Shares Outstanding


Gross Profit Margin


Operating Profit Margin


Net Profit Margin


Return on Assets


Return on Equity


Return on Capital Employed


Company general description and statistics

Sector: Healthcare
Industry: Biotechnology
CEO:Mr. William Michael Brown
Full-time employees:48
Address:Chemin des Aulx, 12

ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. The company is also involved in developing Ebopiprant, an oral and selective prostaglandin F2a, or PGF2a receptor antagonist, which is in Phase II clinical trial as a once daily treatment for preterm labor in weeks 24 to 34 of gestational age; and Nolasiban, an oral oxytocin receptor antagonist that is in Phase I clinical trial to enhance clinical pregnancy and live birth rates in women undergoing in vitro fertilization. ObsEva SA was founded in 2012 and is headquartered in Geneva, Switzerland.

General Outlook

In simple terms, ObsEva SA has 108.022 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 1.000% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -1.761%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -1.522%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -1.806% return, is a testament to ObsEva SA's adeptness in optimizing resource deployment. ObsEva SA's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -3.831%. Furthermore, the proficiency of ObsEva SA in capital utilization is underscored by a remarkable -3.695% return on capital employed.

Stock Prices

ObsEva SA's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.13, while its low point bottomed out at $0.1133. This variance in figures offers investors a lucid insight into the roller-coaster ride that is ObsEva SA's stock market.

Liquidity Ratios

Analyzing OBSV liquidity ratios reveals its financial health of the firm. The current ratio of 222.56% gauges short-term asset coverage for liabilities. The quick ratio (120.73%) assesses immediate liquidity, while the cash ratio (117.23%) indicates cash reserves.

Current Ratio222.56%
Quick Ratio120.73%
Cash Ratio117.23%

Profitability Ratios

OBSV profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -152.10% underscores its earnings before tax deductions. The effective tax rate stands at -0.04%, revealing its tax efficiency. The net income per EBT, 100.04%, and the EBT per EBIT, 86.38%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -176.08%, we grasp its operational profitability.

Pretax Profit Margin-152.10%
Effective Tax Rate-0.04%
Net Income per EBT100.04%
EBT per EBIT86.38%
EBIT per Revenue-176.08%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 2.23, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 7792.46% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

Days of Sales Outstanding121
Receivables Turnover77.92
Fixed Asset Turnover86.51
Asset Turnover1.19

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.25, and free cash flow per share, -0.25, depict cash generation on a per-share basis. The cash per share value, 0.09, showcases liquidity position. Lastly, the operating cash flow sales ratio, -1.18, offers insight into cash flow relative to sales.

Operating Cash Flow per Share-0.25
Free Cash Flow per Share-0.25
Cash per Share0.09
Operating Cash Flow Sales Ratio-1.18
Free Cash Flow to Operating Cash Flow Ratio1.00
Cash Flow Coverage Ratio-7.65
Short Term Coverage Ratio-7.65

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 18.30%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.36, we discern the balance between debt and equity financing. An interest coverage of -2.96 indicates its ability to manage interest expenses.

Debt Ratio18.30%
Debt Equity Ratio0.36
Total Debt to Capitalization26.30%
Interest Coverage-2.96
Cash Flow to Debt Ratio-7.65
Company Equity Multiplier1.95

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 0.21, provides a glimpse into top-line earnings distributed across each share. Net income per share, -0.32, reflects the portion of profit attributed to each share. The book value per share, 0.09, represents the net asset value distributed per share, while the tangible book value per share, 0.09, excludes intangible assets.

Revenue Per Share0.21
Net Income Per Share-0.32
Book Value Per Share0.09
Tangible Book Value Per Share0.09
Shareholders Equity Per Share0.09
Interest Debt Per Share0.13

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 7,954,744.71, captures the company's total value, considering both debt and equity. Income quality, 0.77, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 1.26, gauges operational efficiency, while the research and development to revenue, 54.54%, highlights investment in innovation.

Enterprise Value7,954,744.71
Income Quality0.77
Sales General and Administrative to Revenue1.26
Research and Development to Revenue54.54%
Capex to Operating Cash Flow-0.01%
Capex to Revenue0.02%
Capex to Depreciation0.53%
Stock-Based Compensation to Revenue29.52%
Graham Number0.82
Return on Tangible Assets-180.60%
Graham Net Net0.01
Working Capital8,807,000
Tangible Asset Value8,483,000
Net Current Asset Value7,932,000
Average Receivables1,906,000
Days Sales Outstanding5

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 1.11, and the price to book ratio, 1.11, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.56, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -0.48, and price to operating cash flows, -0.40, gauge market valuation against cash flow metrics.

Price Book Value Ratio1.11
Price to Book Ratio1.11
Price to Sales Ratio0.56
Price Cash Flow Ratio-0.40
Price Earnings to Growth Ratio0.01
Enterprise Value Multiple-1.30
Price Fair Value1.11
Price to Operating Cash Flow Ratio-0.40
Price to Free Cash Flows Ratio-0.48
Price to Tangible Book Ratio1.57
Enterprise Value to Sales0.41
Enterprise Value Over EBITDA-0.53
EV to Operating Cash Flow-0.34
Earnings Yield-223.78%
Free Cash Flow Yield-173.33%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of ObsEva SA (OBSV) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -0.314 in 2024.

What is the ticker symbol of ObsEva SA stock?

The ticker symbol of ObsEva SA stock is OBSV.

What is company IPO date?

IPO date of ObsEva SA is 2018-07-13.

What is company current share price?

Current share price is 0.102 USD.

What is stock market cap today?

The market cap of stock today is 10996640.000.

What is PEG ratio in 2024?

The current 0.006 is 0.006 in 2024.

What is the number of employees in 2024?

In 2024 the company has 48.